Bruker

Precision Oncology Dx Firm Navignostics Raises CHF 7.5 M in Seed Funding From Bruker, Others

The company is developing a system combining single-cell spatial proteomic data with artificial intelligence analysis to guide therapy selection for cancer patients.

Breaking News

Biomarker Identification a Challenge and Opportunity in Cancer Drug Development, Survey Finds
Sanofi Inks €100M Radiopharmaceutical Deal With RadioMedix, Orano Med
Columbia University Leads Project Studying Impact of Genetics, Environment on Drug Responses
Meta-Analysis Questions FDA Warning on Secondary Cancer Risks With CAR T-Cell Therapies
Vir Biotechnology Completes Licensing Deal With Sanofi for Three T-Cell Engager Programs
BridgeBio Discontinues Development of Gene Therapy for Congenital Adrenal Hyperplasia

Bruker

Precision Oncology Dx Firm Navignostics Raises CHF 7.5 M in Seed Funding From Bruker, Others

Biomarker Identification a Challenge and Opportunity in Cancer Drug Development, Survey Finds

Sanofi Inks €100M Radiopharmaceutical Deal With RadioMedix, Orano Med

Columbia University Leads Project Studying Impact of Genetics, Environment on Drug Responses

Meta-Analysis Questions FDA Warning on Secondary Cancer Risks With CAR T-Cell Therapies

Vir Biotechnology Completes Licensing Deal With Sanofi for Three T-Cell Engager Programs

BridgeBio Discontinues Development of Gene Therapy for Congenital Adrenal Hyperplasia